Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1645, 2008-01, pp. : 7-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Tocilizumab adds to benefit with methotrexate in refractory RA
Inpharma, Vol. 1, Iss. 1597, 2007-01 ,pp. :
Access to resources
Recommend
Adalimumab/methotrexate: First report of tularaemia in a patient with RA: case report
Reactions Weekly, Vol. 1, Iss. 1287, 2010-01 ,pp. :
Tocilizumab ± methotrexate beneficial for RA
Inpharma, Vol. 1, Iss. 1562, 2006-01 ,pp. :
Tocilizumab dominates adalimumab for severe RA
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 669, 2013-01 ,pp. :
Ocrelizumab + methotrexate well tolerated in RA
Inpharma, Vol. 1, Iss. 1615, 2007-01 ,pp. :